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Abstract 
It has been suggested that post-traumatic stress disorder sufferers (PTSD) fail to 
extinguish the conditioned fear response to the traumatic stimuli which demonstrates the 
usefulness of an animal model for understanding human PTSD (Milad, 2006; Rauch, 
2006). The N-methly-D-aspartate (NMDA) system plays a critical role in the extinction 
of a fear response. In fact, NMDA antagonism has produced dose dependent blockages 
of extinction (Falls et al., 1992) while ~-cylcoSerine (DCS), and NMDA agonist, has 
shown to be effective in facilitating the extinction process (Walker et al., 2002). 
Experiment 1 did not find results similar to those found in the literature. Interestingly, 
DCS actually facilitated an augmented fear response with 24 hour, 7 day, and 30 delay 
periods between extinction sessions. Experiment 2 also did not find that DCS aids the 
extinction learning process but was able to eliminate the augmentation of the fear 
response found in experiment 1 by extinguishing animals to a criterion level before DCS 
manipulation. The lack of statistical power may have been the largest hindrance on the 
absence of effects seen in experiment 2. However, together these experiments show that 
an initial learning must take place in order for DCS to be effective. Ultimately, if there is 
certain sensitive population with which DCS can be efficacious, then an animal model of 
PTSD which utilizes DCS may be of limited value. In turn, DCS use in humans may 
only render a response in those that exhibit an initial reduction in fear. Otherwise, DCS 
may actually serve to enhance their fear response. 
DCS and Fear Extinction 
The extended effects of D-cycloserine treatment on 
fear extinction in rats. 
Animal research investigating fear, anxiety, and disorders related to such involves 
animal models and typically uses Pavlovian fear conditioning paradigms in which a 
conditioned stimulus (CS), such as a light or tone, is paired with an aversive event 
(shock), or unconditioned stimulus (US). Throughout multiple trials of these pairings, 
the animal becomes conditioned to fear the CS usually causing increased anxiety and a 
conditioned response (CR). For example, rats generally exhibit this fear by freezing, a 
species specific behavior that is characterized by total lack of movement save for 
respiration. Later, in the process of extinction, the CS is presented to the animal in the 
absence of the US. The CR associated with the CS begins to diminish over trials, 
seemingly because this response is no longer adaptive. The conditioned response is thus 
used as an indirect measure of fear and the memory for the CS-US relationship. 
Although it is generally accepted that it is not that the fear has been forgotten, but rather 
the new association of the CS coupled with the absence of the US forms a new memory 
which then competes with the original association for fear expression (Milad et al., 2006). 
Like experimental animals, humans may also employ the same processes to acquire and 
get rid of a fear response. It has been suggested that post-traumatic stress disorder 
sufferers (PTSD), however, fail to extinguish the conditioned fear response to the 
traumatic stimuli which demonstrates the usefulness of this exemplar for understanding 
human PTSD (Milad, 2006; Rauch, 2006). 
Presently, therapies for PTSD and phobias include an exposure-based program, 
which closely resembles the extinction process used in animals (Foa, 2000; Rothbaum & 
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Davis, 2003). Patients are consistently presented with the stimuli once found to be 
traumatic without any negative or aversive consequences in hopes that their fear response 
will diminish over time. Nevertheless, this type of therapy has severe limitations because 
disordered patients typically do not respond normally over time to this form of extinction 
training in that the anxiety response habitually returns and does not usually transfer 
outside the experiment to real world anxiety inducing situations (Foa, 2000; van Minnen 
et al., 2002). Thus, PTSD is typically believed to support the idea of extinction failure. 
Therefore, while the clinical applications of extinction training seems obvious, a 
clearer understanding of the neural mechanisms involved in extinction could generate 
improved biological approaches to treat fear and anxiety related disorders, like PTSD. 
The Role of the Amygdala 
The amygdala has long been implicated in the expression of fear and anxiety. 
The amygdala receives input from several sensory regions and mediates the expression of 
fear as well as anxiety, among other emotional responses (Fendt & Fanselow, 1999) and 
so is essential to formation and expression of aversive memories (Davis et al., 2005; 
Aggleton, 2000). Additionally, the central nucleus of the amygdala may mediate several 
different components of the fear response because it is this area that first projects to 
cortical and brain stem areas that control these responses (Kapp, Silvestri, & Guarraci, 
1998). Barad (2006) also reviews literature indicating that the basolateral amygdala 
(BLA) is central to fear conditioning as well. The information from aversive stimuli is 
first processed in the BLA and is then forwarded to the central nucleus resulting in the 
fear response. 
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In animals, the extinction process can be disrupted by microinjections of NMDA 
receptor antagonists into the amygdala (Falls et al., 1992) and can be facilitated with 
microinjections of an NMDA agonist (Ledgerwood et al., 2003). Although it is believed 
that extinction is an inhibitory learning process, there is some evidence that suggests 
there is at least some reversal of an intact fear memory which occurs in the lateral 
amygdala. Lin et al. (2003) studied depotentiation, or a reversal of long-term potentiation 
(LTP), in the amygdala. Critical to learning and memory formation, LTP is the result of 
compounded neuronal firings, increasing the likelihood of those pathways to activate 
quicker in the future. Conversely, the phenomenon of depotentiation correlates with 
decreases in a conditioned fear response which is thought to be dependent on LTP in the 
amygdala. Thus, decreases in active amygdala pathways leads to a reduction in the 
overall behavioral response to fear. In demonstrating that this decrease (depotentiation) 
could be blocked by NMDA antagonists, Lin et al. (2003) showed that low-frequency 
stimulation of the lateral amygdala elicited this depotentiation (which required NMDA 
activation) as well as attenuated fear expression as measured by a fear-potentiated startle 
paradigm. Thus, they validated that the lateral amygdala is key to extinction memory 
processes and that neural deactivation is a central component to this process. 
The extinction process in human fear conditioning also implicates the amygdala 
as a principal contributor to the process. Both positron-emission tomography (PET) and 
functional magnetic resonance imaging (fMRI) studies have illustrated that amygdala 
activation is heightened during acquisition of conditioned fear (Fischer et a]., 2000; 
Cheng et al., 2003 respectively) and in response to fearful faces in healthy adults (Fischer 
et al., 2003) suggesting there could be deficiencies in top-down control of the amygdala 
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by structures involved in fear extinction for anxiety disordered people (Quirk et al., 
2006). 
Aside from work with healthy participants, clinical evidence has also shown that 
combat veterans with PTSD display an increase in amygdala activation when shown 
masked-fearful faces (Rauch et al., 2000) or reminders of the traumatic event (Liberzon 
et al., (1999) compared to combat-exposed controls as well as healthy participants. 
Thus, the amygdala, and perhaps especially the lateral amygdala, has a profound 
influence on fear acquisition as well as fear expression and these results have been 
replicated in both animal and human experimental settings. However, because the 
literature generally describes the amygdala as a forerunner in fear processing, it is 
perhaps its interplay with other brain regions that are most important in fear extinction 
and ultimately fear expression. The infralimbic cortex (IL), a cortical sub region of the 
prefrontal cortex (PFC), sends an extensive number of connections to the amygdala and 
seems to intercede on amygdala controlled expression of fear as well (Floyd et al., 2001). 
Quirk et al. (2003) demonstrated that IL activation could inhibit the normal amygdala 
mediated behaviors involved in extinction. Consequently, when considering abnormal 
fear acquisition, such as in anxiety disorders, it is perhaps the pathway between the 
amygdala to the prefrontal cortex that could be compromised. 
The Role ofthe Prefrontal Cortex 
Considering the PFC more carefully, the ventral medial prefrontal cortex 
(vmPFC) may also play a large role in extinction learning and expression. It is this 
region that is thought to control the extinction process of long-term memories (Quirk et 
al., 2000). LeDoux et al. (1988) demonstrated that lesions to this area in rats did not have 
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an effect on acquisition of conditioned fear responses but did impair extinction. While 
some laboratories have failed to replicate this finding (Gewirtz et al., 1997), it is 
important to note that the medial prefrontal cortex (mPFC) extends a number of inputs to 
the amygdala and so may modulate the expression of conditioned fear during extinction 
(Milad et al., 2006; Morgan et al., 1993). Others have illustrated that vmPFC lesions, 
specifically those at the IL, do not inhibit extinction learning but may hinder subsequent 
recall at least one day later (Quirk et al., 2000) or impair the process such that it requires 
more initial training for equal results compared to control animals (Lebron et al., 2004). 
In the study performed by Lebron and colleagues (2004), rats with lesions of the 
vmPFC extinguished normally but were impaired in extinction recall 24 hours later. 
Additionally, lesioned rats needed twice as many days to initiate extinction compared to 
control animals. This implicates the vmPFC as a storage site for extinction memories. 
However, lesioned animals responded to subsequent extinction sessions faster than 
lesioned counterpart rats without prior extinction experience. This ultimately proposes 
that vmPFC is not the sole site of extinction memories but it is a necessary component for 
adequate recall and access to extinction memories. Therefore, the vmPFC must be vital 
for the consolidation of extinction memories so that it is available for recall (Milad et al., 
2006) and the collection of animal studies supports this notion. 
Aside from lesion studies, recording investigations have also demonstrated that 
long-term potentiation (LTP) can result from the stimulation of glutamatergic pathways 
connecting to the mPFC (see Quirk, 2006 for review). Focus on such prefrontal 
pathways indicate that the mediodorsal thalamus (MD) pathway shows definite LTP- 
related changes with extinction training and that inactivation of the PFC by the thalamus 
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is associated with extinction recall (Heny & Garcia, 2002). However, disabling the MD- 
PFC pathway leads to a full recovery of the initial fear after extinction trials (Herry & 
Garcia, 2002). 
In a recent review of prefrontal mechanisms involved in extinction, Barrett and 
colleagues (2003) concluded that the mPFC showed the most metabolic activity after 
extinction, specifically in the IL sub region. Furthermore, one such study reported 
positive correlations existing with the mPFC and areas associated with inhibition and 
extinction behavior and inverse correlations existing between the mPFC and areas 
associated with the expression of conditioned fear (Quirk, 2006). Together, these 
analyses support the idea that the prefrontal cortex, and perhaps especially its infralimbic 
region, is critical to consolidating extinction sessions into long-term storage and recalling 
those memories so that fear expression can be inhibited. 
As mentioned, the PFC may be of most importance to fear extinction because its 
role may be to countermand or supersede the amygdala response to fear and thus hinder 
its expression. Quirk et al. (2006) describes this process as a feed-forward inhibition of 
the amygdala output neurons. In support of this idea, Quirk et al. (2003) and Milad et al. 
(2004) stimulated the IL which lead to decreased activity in pathways from the amygdala 
to the brainstem and also lead to decreases in common measures of fear expression. In 
turn, this directed interest towards ways to improve the extinction process by enhancing 
prefrontal mechanisms. Herry and Garcia (2002) stimulated the medial dorsal (MD) 
inputs before extinction training and reported no significant differences during extinction 
sessions. However, when tested 1 week later, the recollection for the extinction training 
was distinctly improved. They concluded that their LTP-evoking stimulation of mPFC 
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pathways prevented the normal decay of extinction memory that occurs over time. 
Indeed, electrical stimulation of the mPFC strengthens extinction learning and decreases 
fear behavior (Quirk, 2006). Thus, LTP of extinction, which is creating the new memory 
for extinction training, is ultimately related to synaptic strength in the PFC. 
Similar to animal studies, research into the human fear experience parallels the 
findings often seen in laboratory settings. In such cases, prefrontal activation was seen 
during the recall of extinction (Phelps et al., 2004) and specifically during the extinction 
of eye blink conditioning suggesting that even in humans, the prefrontal cortex is 
necessary for aversive conditioning and fear learning (Rauch et al., 2006). PTSD 
sufferers also seem to show augmented perseveration in object-alternation tasks which 
involve the prefrontal cortex (Koenen et al., 2001). Thus, it seems that the animal 
literature parallels human findings of prefrontal deficiencies during the extinction process 
of fear conditioning and learning. One hypothesis involves the connection between the 
prefrontal regions and the amygdala. That is, a top-down failure of inhibition of the 
amygdala by the vmPFC (Rauch et al., 2000). However, some have also suggested a 
bottom-up malfunction of pre-existing amygdala dysfunction which later results in 
prefrontal interruption (Milad et al., 2006). These hypotheses could be further tested with 
longitudinal examinations of irregularities in either the PFC or amygdala, or both, from a 
developmental perspective. 
It is thoroughly evident, however, that the prefrontal cortex does seem to play a 
role in the inhibition of general cognition (Bremner et al., 2000). This may explain the 
intrusive thoughts, or flashbacks, often experienced by sufferers of PTSD, specifically 
with combat related stress. One form of treatment that is common is the use of 
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benzodiazepines. This has shown to be effective in therapy but does not seem to prevent 
PTSD (Bremner et al., 2000) suggesting that there are certain alterations in 
benzodiazepine receptors that occur during the stress provoking period. These alterations 
may be most prevalent in the prefrontal cortex. Bremner et al. (2000) found that Vietnam 
War veterans with PTSD had prefrontal benzodiazepine distribution volumes 41% lower 
than that of healthy comparison subjects. One explanation which was offered suggested 
that perhaps a preexisting low level of benzodiazepine receptors in the prefrontal cortex 
may be a risk factor for developing PTSD. 
While investigating another clinical population, Bremner (2002) reported that 
PTSD sufferers showed reduced overall activity of the PFC, while Rauch et al. (2003) 
added that recorded volumes of the perigenual PFC were significantly lower in PTSD 
populations. It is perhaps the genetic integrity of the prefrontal cortex which could pose 
as a risk factor in developing anxiety disorders, especially PTSD. Milad et al. (2005) 
suggested that the preservation of fear extinction memory is correlated with prefrontal 
cortical thickness. Therefore, if the prefrontal cortex is compromised, it is likely that the 
extinction process will be as well. 
The Role of the NMDA System 
Yet another system that may influence fear learning, at least in the amygdala, is 
the glutamate receptor of the N-methyl-D-aspartate (NMDA) type (Davis, 2005). Some 
forms of long-term potentiation (LTP) have been known to be dependent on NMDA 
receptor activity which point to this system's role in memory consolidation (Quartermain 
et al., 1994). Lanthom (1993) states that since LTP is a necessary component of learning 
and memory and that the NMDA system seems to play an integral role, its specific 
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modulation may also underlie disorders of learning and memory and thus their treatment. 
According to Lanthom (1993), the pattern of neural activation favorable to LTP matches 
that which is also favorable to NMDA activation. This pattern consists of one stimulus 
which disinhibits neural responses via the GABAergic system. A second stimulus, not 
more than 250 milliseconds later, produces a cumulative depolarization which in total is 
sufficient to activate NMDA channels. Essentially, the stimulation of the NMDA 
receptor complex increases the probability of inducing LTP (Lanthom, 1993). 
Interestingly, acquisition of fear has not been shown to be affected by NMDA 
agonism so it may be that only extinction, or learning to inhibit a response that is no 
longer adaptive, is affected by the NMDA system (Davis, 2005). In fact, NMDA 
antagonism has produced dose dependent blockages of extinction (Falls et al., 1992). At 
least one explanation for the discrepant findings comparing NMDA's role in acquisition 
and extinction is that NMDA and glycine share similar chemically structural components 
and therefore bind to the same site on the NMDA receptor. In this case, it may be 
possible that glycine is already be inundating these sites during acquisition, thus 
hindering any attempts made by NMDA to bind there (Davis, 2005). 
What is perhaps the most interesting to note is that NMDA blockers need only to 
be administered around the time of extinction, rather than only before or after an 
extinction session. While numerous studies have illustrated that d-cycloserine (DCS), an 
NMDA agonist, given prior to training can enhance performance and memoly for 
extinction (see Lanthom, 1993 for review), it has also been demonstrated that 
administration 3 hours post-extinction was sufficient to impair extinction recall in rats up 
to 24 hours later (Ledgerwood et al., 2003). Flood et al. (1992) also validated that DCS 
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administered post-training could aid retention of a T-maze (with foot shock) paradigm. 
These authors claim that DCS enhanced neural changes that typically occur shortly after 
learning sessions. 
Although NMDA agonism may not be dependent on the order of drug 
administration with a learning task, activation's beneficial effects may be constrained by 
administration frequency. Quartermain et al. (1994) reported mice treated with DCS for 
15 days performed significantly poorer in a spatial memory test for retention compared to 
mice that only received single injections. Their study demonstrated that chronic NMDA 
activation could lead to receptor desensitization. Thus, the NMDA system appears to be 
important to both the consolidation and maintenance of extinction learning, a system that 
could very well be malfunctioning in PTSD sufferers. On the other hand, chronic NMDA 
activation could prove to be an ineffective form of treatment. Therefore, perhaps the 
sensitivity of these related systems provides only a narrow range of treatment courses that 
do not result in impairments to extinction learning. 
One clear advantage of investigating the role of NMDA in PTSD is the clinical 
relevance and usefulness of such approaches. DCS is a clinically safe compound that has 
been used to treat tuberculosis and has shown antibacterial effects at high doses (Davis, 
2005) due to its ability to inhibit the metabolism of the amino acid, L-alanine (Baran et 
al., 1995). At high doses, DCS has been known to produce antidepressant and anxiolytic 
effects (Crane, 1959). Thus, exposure based programs used in conjunction with DCS 
could provide the best option for treatment and would subsequently add to the validity of 
animal models of PTSD. Indeed, some double-blind, placebo controlled studies have 
shown that DCS can improve associative learning in people with phobias (Ressler, 2004). 
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While there may be physiological abnormalities that distinguish clinically anxious 
people from those who are not, the evidence with animal extinction learning discerns that 
perhaps there is an emotional learning component which allows for the malformation of 
fear memories. It is thusly believed that pharmacological treatment, to combat the 
physiological dysfunction, and behavioral therapy, to resist the maladaptive learning, is 
the best options for treatment. This combination has been tested in both pre-clinical and 
situations that mimic those of animal extinction training. 
Ressler et al. (2004) examined 27 patients with DSM-IV criteria for acrophobia in 
a virtual reality exposure paradigm (VRE) where participants controlled a virtual elevator 
upwards and stopped at the highest floor they could manage. The trial was double-blind 
and placebo controlled. Initially the authors found that DCS does not affect the level of 
fear or of avoidance during the first exposure (extinctiodtherapy day 1). Therefore, any 
promising results could not be attributed to any anxiolytic effects of DCS. However, 
during the second exposure, DCS patients demonstrated significantly lower subjective 
ratings of discomfort and elevated to significantly higher floors. This established that the 
facilitory effects of DCS occur during the intersession retention interval. 
These positive outcomes were maintained after a 3 month follow-up period. 
Additionally, patients who had received DCS reported significantly more comfortability 
and less anxiousness in real-world height situations. In fact, they reported twice as many 
such encounters during the 3 month period. DCS also aided in reducing objective 
measures of anxiety. Those patients receiving DCS had significantly fewer spontaneous 
skin conductance fluctuations, a measure that is negatively correlated with anxiety, 
compared to those patients that did not receive DCS treatment. 
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As robust and lasting the results from this study are it is uncertain if these long 
lasting reductions in fear were the result of more extinction sessions in the DCS groups. 
In other words, it is presumed that the initial learning was sufficient to empower the DCS 
patients to face more real-world heights, and then these people are expected to face more 
response evoking situations without aversive consequences, in essence more extinction 
sessions. It is certainly plausible to consider that untreated groups would have had the 
same outcome had they confronted more real-world heights. Therefore, one cannot 
assume that DCS provided this reduction in overall fear level. Rather, its conjunction 
with additional extinction learning experiences may have contributed to the effect seen. 
Hofmann (2007) also reported similar results pairing DCS dosing with an 
exposure-based therapy program. In his clinical study, social anxiety patients made 
public speeches of increasing difficulty. Those who had been administered the DCS 
treatment exhibited significantly greater post-treatment improvements on clinical and 
self-report assessments of anxiety compared to patients receiving placebo treatment. 
Moreover, these results were maintained at a one month follow up evaluation. 
Other clinical investigations have employed DCS as treatment for anxiety based 
disorders. Kushner et al. (2007) is currently focusing on acute administration of DCS and 
effectiveness of exposure therapy and response prevention in obsessive-compulsive 
disorder. Preliminary results thus far have shown that there are significant reductions in 
obsession-related distress compared to a placebo control group. 
Furthermore, Tolin et al. (2006) explored the use of DCS with panic disorder. In 
their exposure-based program, they also presented significantly greater reductions in both 
clinical and self-report measures of panic disorder severity compared to placebo 
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counterparts. More impressively though, their findings indicated that 62% of patients 
receiving DCS were considered to be in remission compared to 21% of the placebo 
patients. After the follow-up interval, 75% of DCS patients were considered to be in 
remission compared to only 3 1% of placebo patients. 
Noticeably advantageous results have sprung from clinical and animal studies 
utilizing DCS in exposure-based programs and extinction paradigms. Yet many patients 
still fail with such treatments. It is possible with perhaps better animal and sub-clinical 
models of anxiety disorders to observe larger and longer lasting effects of DCS. 
Animal models have characteristically employed acute administrations of DCS 
and there is only one known study of sub-chronic or multiple administrations of DCS 
given during the extinction process (Pamas et al., 2005). Additionally, these single doses 
of DCS do not seem to have lasting effects on subsequent extinction trials (Silvestri, 
Kyek, & LeBlanc, 2007), yet long term treatment was not assessed. Presumably, 
treatment for phobias, panic disorder and PTSD would include multiple sessions of 
therapeutic exposure so it is important to assess whether an inhibited fear response can be 
sustained over longer periods of time and if drug administration could facilitate fear 
inhibition retention and reduce overall spontaneous recovery. At least two human studies 
showed that DCS has long lasting effects, yet no one has investigated the usefulness of an 
animal model. Pamas and colleagues (2005) reported that a 28 day period of pre- 
exposure of animals to DCS before acquisition training facilitated the extinction process 
but that this result was not found with pre-exposure just prior to acquisition training. 
Accordingly, it may be advantageous to test the duration of extinction facilitation while 
manipulating the inter-session interval and thus memory consolidation periods. 
DCS and Fear Extinction 
Pilot Study 
Methods 
Subjects 
The subjects were 13 experimentally nake male Sprague-Dawley rats. All 
animals weighed between 250 and 350 grams throughout the duration of the experiment. 
Food and water were available ad libitum. Rats were kept on a 12:12 hour light-dark 
cycle (lights on at 8am) and housed in pairs (one rat housed singly). 
Apparatus 
Fear conditioning was conducted in standard conditioning chambers using a light 
and noise conditioned stimuli presentation as well as a floor grid equipped to deliver 
shock. The shock was transferred via an ENV-414 shock/distributor (MED Associates, 
Inc., Georgia, VT) and the light and noise were conveyed by means of a custom written 
computer program using MED-PC (MED Associates Inc., Georgia, VT). 
Procedure 
Rats were handled for at least twice in 10 minute sessions prior to 
experimentation beginning up to 2 weeks after anival. To habituate animals to the 
context, one habituation session was given prior to fear conditioning. For this, rats were 
placed into the conditioning chamber for 45 minutes with the same white noise that was 
present during conditioning. 
For acquisition training, rats were again placed into the conditioning chamber and 
presented with 10 lighthoise (CS) plus shock (US) pairings. The intensity of the shock 
and number of training sessions was manipulated to investigate which condition would 
provide the maximum amount of freezing that could be sustained over longer periods of 
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time. Rats were subjected to either a SmA or 1.OmA shock in either one 10 trial session 
or two 10 trail sessions separated by 24 hours (Table 1). The rationale for such an 
investigation developed because an earlier study was unable to detect long term 
differences between groups seemingly because freezing had reached a minimal value (in 
essence a floor effect) too quickly (Silvestri, Kyek & LeBlanc, 2007). If extended effects 
of DCS are of particular interest, it is necessary that animals are trained under conditions 
that would maximize keezing during extinction so that if a difference does exist it can be 
recognized in multiple extinction sessions beyond just the first. One way to combat this 
issue may be to create a stronger initial conditioned fear association by increasing shock 
intensity andlor increasing the number of CS-US pairings. 
Two initial extinction sessions were given after acquisition training concluded and 
were each separated by 24 hours. A third identical extinction session was given 1 week 
following the second. For each of these sessions, rats were placed into the conditioning 
chamber and presented with 10 CS alone trials. The percentage of time spent freezing 
during the 30 second CS presentation was recorded by trained observers. 
SHOCK I I0 TRIALS 20 TRIALS OVER INTENSITY 2 DAYS TOTAL 
Table 1. Pilot study manipulation of shock intensity and duration of acquisition 
1.0 mA N= 3 N= 4 N= 7 
TOTAL N= 6 N= 7 N= 13 
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Data Analysis 
Each rat was scored for freezing during each of the acquisition and extinction 
sessions. Freezing was considered to be a lack of all bodily movement except that 
required for breathing and was measured using a time sampling method. An observation 
was made every 3 seconds and a positive or negative judgment was made. A percentage 
score was then calculated for the proportion of the total observation time period spent 
freezing (Weber et al., 2007). Because only qualitative measures of freezing levels were 
necessary to determine the best methods to employ for the study's experiments, no 
quantitative data analyses were conducted. A close visual inspection of the graphic 
representations of the results was performed and logically informed judgments were 
made based upon these. 
Results 
The results of the pilot experiment illustrated that shock intensity did not factor 
into the strength of the conditioned fear association during the initial extinction sessions 
(Figure 2-3 left). However, rats who had received the larger intensity shock did sustain a 
more pronounced conditioned response one week later during a third extinction session 
(Figure 4 left). This is presumably because there is not a difference between a .75mA 
shock and a 1.OmA shock in terms of initial aversiveness yet the salience of a larger 
shock may have been large enough to sustain a greater fear response over an extended 
period of time. When rats were given 20 training trials over two days, their freezing 
during both extinction trials remained heightened compared to the freezing behavior 
exhibited by the rats only receiving 10 training trials on one day (Figures 2-3 right). 
Thus, it was concluded that the condition which induced the strongest initial association 
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for the fear related stimuli as well as the strongest sustained fear response was that which 
received 1 .GmA shocks and 20 acquisition trials which increased the duration of training 
as well as the intensity of the shock (Figure 5). 
Extinction 1 
-P-- .75mA 10 trials 
4 1 .OmA 20 trials I 
'0 L- 
1 2 3 4 5  
d 
1 2 3 4 5  
Blocks of 2 Trials 
Figure 1. First extinction session (24 hrs. after acquisition training). Left side shows 
groups collapsed across shock intensity. Right side shows groups collapsed across 
number of training trials (20 trials is over 2 consecutive days). 
Extinction 2 
-c- .75mA 10 trials 
-A- l.OmA 20 trials 
100, -- 
Blocks of 2 Trials 
Figure 2. Second extinction session (24 hrs. after extinction 1). Left side shows groups 
collapsed across shock intensity. Right side shows groups collapsed across number of 
training trials (20 trials is over 2 consecutive days). 
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Extinction 3 
.75mA 10 trials 
-A- I .OmA 20 tlials 
100 
90 - 
Blocks of 2 Trials 
Figure 3. Third extinction session (7 days after the extinction 2). Left side shows groups 
collapsed across shock intensity. Right side shows groups collapsed across number of 
training trials (20 trials is over 2 consecutive days). 
r- .75mNlO trials I 
Extinction 3 - 1.0mN10 trials 
- .75mN20 trials (2d) 
Figure 4. The group receiving both the greater 1.OrnA shock and increased training trials 
seemed to be the only group sustaining a more enhanced fear response indicated as the 
only group that remained above 50% freezing throughout the session. 
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Experiment I 
Methods 
Subjects 
The subjects were 21 experimentally na'ive male Sprague-Dawley rats. All 
animals were between 250 and 350 grams throughout the duration of the experiments. 
Food and water were available ad libitum. Rats were kept on a 12:12 hour light-dark 
cycle (lights on at 8am) and housed in pairs. All protocols were approved by the Seton 
Hall Animal Use and Care Committee and all guidelines for the care and use of animals 
set by the United States Public Health were strictly followed. 
Apparatus 
The apparatus used was identical to that used in the pilot study. 
Procedure 
Handling and habituation procedures were identical to that used in the pilot study. 
For acquisition training rats were again placed into the conditioning chamber and 
presented with 10 lighthoise plus shock parings (lighthoise: 5 seconds; shock: 0.5 
seconds, 1 .OmA; 120 second variable intertribal interval). After this training session, rats 
were returned to their home cages. Twenty-four hours later, another conditioning session 
was administered using the same conditioning procedure described above. 
The first extinction session took place 24 hours after this initial conditioning 
session. For this, rats were placed into the conditioning chamber and presented with 10 
lighthoke alone trials. An identical second extinction session was administered to all 
rats 24 hours following the first session. There were four experimental groups consisting 
of rats that received subsequent extinction sessions beginning 24 hrs., 7 days, or 30 days 
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after the initial two extinction sessions to assess both memory for extinction training and 
analyze the extended effects of DCS treatment (Figure 6). Such time intervals were 
chosen because Parnas et al. (2005) had demonstrated that DCS can have long-lasting 
effects on extinction but their animals werepre-exposed to DCS prior to acquisition. The 
extended effects of drug administration given after initial extinction sessions were not 
assessed. Therefore, a delay of at least 4 weeks was necessary; however it seemed 
appropriate to evaluate the developing time-course effects of DCS at shorter intervals as 
well. The 24 hr. delayed group was the only group to receive extinction sessions each 
day until hlly extinguished or until the drug group is no longer significantly different 
than the control group. All other delay groups received extinction sessions spaced apart 
by their respective time delays. 
24 hrs. apart 
(24 hrs. later) 
(24 hrs. later) 
I n 
24 hn. post injection 7 days post injection 30 days post injection 
N =3 N =3 N =5 N =4 
I I I 
48 hn. post injection 14 days post injection 60 days post injection 
N =3 N =3 
Figure 5. Schematic representation of experiment 1 
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D-cycloserine (DCS) was obtained from Sigma Chemical Company. Rats were 
first trained and given the first extinction session as described in the procedure above. 
Immediately after this first extinction session, rats were given a systemic injection of 
either 30 mgkg DCS or vehicle. The same injection was given after the second 
extinction session only. No rats were given injections after any subsequent extinction 
sessions. 
The rationale for administering the drug post-extinction came from previous 
studies that showed no behavioral differences from drug administrations given prior to or 
after extinction sessions (see introduction). Therefore it seemed advantageous to 
minimize the effects of state dependent learning which could result from an anxiety 
provoking state due to injections given before extinction session. 
Data Analysis 
The methods used to analyze the amount of freezing were identical to that used in 
the pilot study. Mixed factorial ANOVA was the primary statistical approach for all 
acquisition and extinction sessions. The between-subject factors were drug treatment and 
delay while the within-subjects factor was blocks. In each analysis, the dependent 
measure was percentage of time spent freezing and the independent variables were trial 
block and delay group. Each trial block consisted of 2 trials (Woods & Bouton, 2006). A 
rejection criterion ofp  <.05 was used for all analyses. 
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Results 
Acquisition 
The first and second acquisition sessions were combined to have an overall 
indication of acquisition behavior. The analysis was conducted as a Groups (2) x Blocks 
(10) x Delay group (3) design with blocks as a within-subject variable and delay and 
group as between subjects variable. And, since the analyses of these sessions were only 
used to have assurance that animals acquired an observable amount of fear, no analyses 
between acquisition sessions was necessary. A main effect of blocks was observed 
indicating that animals' freezing behavior significantly increased over trials [F (9, 135) = 
14.312, p =.000] (Figure 7). There was also a main effect of delay group [F (2, 15) = 
5.262, p = ,019). A Tukey's HSD post-hoc analysis revealed a difference between the 7 
day and 30 day delay groups [F (2, 15) = 5.262, p = .015). The difference is largely due 
to slightly less freezing overall in the 30 day group compared to the 7 day group. Figure 
7). There was no main effect of drug group which signifies that these two groups did not 
differ in terms of acquisition behavior before the drug manipulation took place. There 
were also no interaction effects between any of these variables. 
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I 2 3 4 5 6 7 8 9 0  I 2 3 4 5 6 7 8 9 0  I 2 3 4 5 6 7 8 9 0  
24 HR 7  DAY 30 DAY 
Blocks 
Figure 6. Acquisition 1 and 2. Blocks 1-5 reflect first acquisition; blocks 6-10 reflect the 
second acquisition session. 
Initial Extinction 
Extinctions 1 and 2 were combined to have an overall indication of initial 
extinction behavior. Injections of DCS or vehicle were given only after these sessions 
which were separated by 24 hours. They were also unique in that the time delay 
manipulation did not take place until after these initial extinction sessions. 
The initial extinction data are shown in Figure 8. In this groups x trials mixed 
factorial design, there was a main effect of blocks indicating that animals' freezing 
behavior significantly decreased over trials [F (9, 135) = 20.035, p =.000]. Also, a main 
effect of drug group was detected [F (1, 15) = 14.536, p = .002], however contrary to the 
initial hypothesis, animals treated with DCS had significantly heightened levels of 
freezing compared to rats treated with vehicle. Additionally, a main effect of delay group 
[F (2, 15) = 5.109, p = .020] demonstrated that the groups may have differed before the 
time delay took place. 
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Similarly, significant blocks x delay group [F (18, 135) = 3.672, p = .000] and 
blocks x drug group interactions [F (9, 135) = 2.836, p = ,0041 were found which reflect 
the differences that diverge the 7 day delay group from the 24 hour and 30 day groups in 
terms of initial extinction behavior. Interestingly, there was a marginally significant 
blocks x drug group x delay group interaction [F (1 8, 135) = 1.48 1, p = ,1061 which may 
indicate further that these groups not only differed in terms of their initial freezing 
behavior, but also in terms of their responsiveness to DCS (Figure 8). 
Initial Extinction 
1 2 3 4 5 6 7 0 9 0  1 2 3 4 5 6 7 8 9 0  1 2 3 4 5 6 7 8 9 0  
24 HRS 7 DAYS a DAYS 
Blocks 
Figure 7. Initial Extinction. Blocks 1-5 reflects the first extinction session while blocks 
6-1 0 reflect the second extinction session. 
Delayed Extinction 
In figure 9, extinctions 3 and 4 were combined to evaluate the overall indication 
of delayed extinction behavior. Injections of DCS or vehicle were not given only these 
sessions and so they reflect the behavior patterns of rats after acute injections of DCS or 
vehicle and a time delay. 
A main effect of blocks was found [F (9, 135) = 2.898, p = ,0041 indicating that 
decreases in freezing levels were still occumng after these time delays. There was also a 
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main effect of drug [F (1, 15) = 18.234, p = .001] where animals treated with DCS 
displayed significantly greater amount of freezing during these later delayed extinction 
sessions. Additionally, a main effect of delay group [F (2, 15) = 4.074, p = .039] 
indicates that the amount of initial extinction retained during these later sessions differed 
with respect to delay group. Tukey's HSD post-hoc analyses revealed a difference 
between the 24 hour and 7 day delay groups [F (2, 15) = 4.074, p = ,0411 as well as 
between the 24 hour and 30 day delay groups, however this difference is only marginally 
significant [F (2, 15) = 4.074, p = ,0831 (Figure 9). The graph suggests a significant 
three-way interaction with the greatest drug effect in the 30 day group and the least in the 
7 day group ,but the interaction was not significant, F(13, 195) = 1.3, p > .05. This lack 
of significance is most likely due to the high degree of variability in the data when all 
three groups are included in the analysis. For example, if separate ANOVAs are 
calculated on the three delay groups a significant drug x blocks interaction was observed 
in the 30 day group, F( 9,36) = 2.30, but not the 7 day group, F(9,63) < 1, or the 24 hr 
group, F(9, 36) = 1.40, p > .05. 
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100 I 
1 2 3 4 5 6 7 8 9 1 0  1 2 3 4 5 6 7 8 9 1 0  1 2 3 4 5 6 7 8 9 1 0  
24HR 7 DAY 30 DAY 
Blocks 
Figure 8. Delayed Extinction. Blocks 1-5 reflect extinction 3 (24 hrs, 7 days, or 30 days 
after extinction 2). Blocks 6-10 reflect extinction 4 (48 hrs, 14 days, or 60 days after 
extinction 2). 
Discussion 
The experiment revealed that intraperitoneal administrations of DCS following 
initial extinction session serves more to augment the fear associated behavior rather than 
to reduce it. This is in contrast to a number of studies demonstrating that DCS enhances 
extinction (Lanthom, 1993; Flood et al., 1992; Parnas et al., 2005). There are several 
different reasons for the disparity in these results. 
The seemingly beneficial effects of DCS stem from its neural underpinnings. By 
binding to the glycine receptor site on the NMDA receptor complex, DCS facilitates 
excitatory NMDA transmission which has been linked to long-term potentiation (LTP) 
and ultimately, learning (Quartermain et a]., 1994). Moreover, NMDA 
neurotransmission is a possible mechanism by which experiences are translated from 
short-term to long-term memory (Sweatt, 1999). Assuming that short-term memories are 
necessary for long-term memory formation, it may be crucial to ascertain if short-term 
memories are in fact being formed during initial extinction sessions. 
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Only one other known study has formally addressed this issue. Weber, Hart, and 
Richardson (2007) investigated the effects of DCS on extinction of learned fear to an 
olfactory cue and determined that DCS is ineffective at facilitating extinction retention if 
no short-term extinction learning occurs prior to injection. The present study certainly 
supports this idea by demonstrating that when there was no effect of trials during 
extinction session 1 (prior to injections) or 2 (prior to 2nd injection), there was essentially 
no initial extinction learning that took place. Under these conditions, DCS would be 
predicted to be ineffective; this lack of effect is precisely what was observed in the 
present study. 
Therefore, while DCS may facilitate NMDA transmission, its qualitative effects 
on fear related behavior may translate to its ability to convert short-term into long-term 
memories. Based on these findings, Weber et al. (2007) consequently divided animals 
into groups of "extinguishers" and "non-extinguishers" and found that when there was a 
significant amount of extinction in the short-term; DCS was facilitative in converting 
those memories into long-term memories as evidenced by retention tests. They 
concluded that this reflects a "quantitative" effect that DCS may have on memory, 
augmenting the amount of information that can be transferred into long-term storage. 
Such an argument could be used to explain the behavior found in the 7 day delay group, 
which never produced group differences at any time point in extinction training. Still, the 
performance in both the 24 hour and 30 day delay groups cannot be completely explained 
in the same manner. Their fear associated behavior was counter to both the original 
hypothesis and previous studies exploring DCS and extinction (Lanthom, 1993; Flood et 
al., 1992; Parnas et al., 2005) in that DCS treated animals reliably displayed more fear 
DCS and Fear Extinction 
related behavior than did control animals which seems to indicate a more complex nature 
of NMDA neurotransmission and its role in extinction learning. 
DCS may serve better to strengthen initial extinction learning such that it is less 
susceptible to decay over time (Weber et al., 2007). This concept is borrowed from 
Rescorla (2004) who established that, in associative learning paradigms, what is learned 
first is the most resilient compared to what is learned later, elucidating why extinguished 
responses "spontaneously recover" after time. In other words, the acquisition training 
given could impair subsequent extinction learning retention and DCS may aid extinction 
learning by hindering spontaneous recovery. Presently, the 24 hour and 30 day delay 
groups illustrated that the amount of spontaneous recovery (block 1 in extinction sessions 
2-4) was greater in the DCS treated animals. Thus, it is hypothesized here that not only 
was DCS ineffective at aiding extinction learning, but that it actually supported a more 
robust recovery after short (24 hours) and extended (30 days) but not intermediate (7 
days) periods of time. Perhaps during these short and long retention intervals, DCS was 
able to enhance the last associative learning session, namely acquisition because the 
argument can be made that no learning took place during the extinction session prior to 
the DCS injection. Furthermore, if DCS serves to strengthen long-term memories, such 
that they are less susceptible to degradation over time (Weber et al., 2007), and if 
acquisition was the last long-term memory which was formed, then the present results 
could be indicating that DCS facilitatied the strengthening of that memory which was 
obvious after both short (24 hours) and long (30 days) delays. 
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Experiment 2 
This experiment was designed to test the previously stated hypothesis that the lack 
of effect of DCS in the first experiment was due to a failure to learn the initial extinction 
training. This objective will be accomplished by confirming all animals learn a criterion 
amount of extinction training before given injections of DCS or vehicle. 
Methods 
Subjects 
The subjects were 18 experimentally naive male Sprague-Dawley rats. All 
animals were between 250 and 350 grams throughout the duration of the experiments. 
Food and water were available ad libitum. Rats were kept on a 12:12 hour light-dark 
cycle (lights on at Sam) and housed in pairs. All protocols were approved by the Seton 
Hall Animal Use and Care Committee and all guidelines for the care and use of animals 
set by the United States Public Health were strictly followed. 
Apparatus 
The apparatus used was identical to that used in the pilot study and in the first 
experiment. 
Procedure 
The procedures were identical to that of the first experiment with the exception of 
the number of initial (pre-drug) extinction trials. Rather than two extinction sessions 
followed by DCS or vehicle injections, animals now received as many extinction sessions 
necessary until extinction learning was demonstrated. For this, rats were given an 
extinction session every 24 hours after acquisition training until the average freezing 
during the final block of the session reached 50% of their original recalled fear magnitude 
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(measured as the amount of freezing exhibited during the first block of the first extinction 
session). The time delay manipulation was not taken into consideration until the animal 
had reached criterion freezing levels. Therefore, once the animals reached criterion, they 
were given a single injection of DCS or vehicle and placed back in their home cages for 
the 24 hour, 7 day, or 30 day delay period as described in the first experiment. 
Drug 
The drug used was identical to that used in the first experiment. 
Data Analysis 
The methods used to analyze the amount of freezing were identical to that used in 
the pilot study and the first experiment. Mixed Factorial ANOVA was the primary 
statistical approach for all acquisition and extinction sessions. In each analysis, the 
dependent measure was percentage of time spent freezing and the independent variables 
were trial block as a within-subjects factor and delay and drug treatment as between- 
subjects factors . Each trial block consisted of 2 trials (Woods & Bouton, 2006). A 
rejection criterion ofp <.05 was used for all analyses. 
Results 
Acquisition 
The first and second acquisition sessions were combined to have an overall 
indication of acquisition behavior. Since the analyses of these sessions were only used to 
have assurance that animals acquired an observable amount of fear, no analyses between 
acquisition sessions was necessary. A main effect of blocks was observed indicating that 
animals' freezing behavior significantly increased over trials [F (9, 153) = 29.90, p=.000] 
(Figure 10). There was no main effect of delay group, nor was there a main effect of 
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drug group which signifies that these two groups did not differ in terms of acquisition 
behavior before the drug manipulation took place. There were also no interaction effects 
between any of these variables. 
Acquisition 
24 HRS 7 DAYS 
Blocks 
Figure 9. Acquisition. Blocks 1-5 reflect acquisition 1 while blocks 6-10 reflect 
acquisition session 2. 
Extinction 
The first and second extinction sessions were combined to have an overall 
indication of extinction behavior. A main effect of blocks was found indicating freezing 
behavior has significantly decreased over the course of 10 blocks (20 trials) of extinction 
[F (9, 117) = 1 1.226, p = .000]. There was no main effect of drug group ( ~ t a '  = ,018) but 
there was a significant main effect of delay group [F (2, 13) = 4.228, p = .039]. Tukey's 
HSD post-hoc analysis revealed that rats remained at more elevated levels of freezing 
when extinction took place 24 hours following drughehide administration compared to 
when it took place 30 days following. There was also a marginally significant difference 
between the 24 hr. delay group and the 7 day delay group [F (2, 13) = 4.228, p = .090]. 
Similar to the difference found between the 24 hr. and 30 day delay groups, this analysis 
indicated that overall freezing levels were higher in the 24 hr. delay group compared to 
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the 7 day delay group. While there was no interaction between drug group and delay 
group ( ~ t a '  = .220), or blocks (Eta2 = .042), nor between blocks x delay group x drug 
group (Eta2 = .097), there was an interaction effect observed between blocks and delay 
group [F (18, 117) = 1.836, p = ,0291. More specifically this interaction is due to a 
greater decline in freezing over blocks in the 24 hr and the 30 day groups than in the 7 
day group. (Figure 1 1). 
Extinction 
100 , 
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Figure 10. Extinction. Blocks 1-5 reflect extinction 1 while blocks 6-10 reflect extinction 
session 2. 
Discussion 
The results of the second experiment do not coincide with the animal literature 
demonstrating that NMDA agonism can aid the extinction process (Ledgerwood et al., 
2003). Nor do the results corroborate with the more specific clinical literature that 
implicates DCS as an effective compound to use in extinction-like exposure therapy for 
anxiety disorder sufferers (Ressler et al., 2004; Tolin et al., 2006; Kushner et al., 2007; 
Hofmann et al., 2008). Again, the underlying causes of these results are unknown. There 
are perhaps methodological issues that can be addressed, 
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The amount of statistical power to detect group differences is a clear hindrance on 
supporting the original hypothesis. Based on visual observation alone, it appears as 
though DCS has a facilitory effect on extinction learning, especially for short (24-48 
hours) and intermediate (7-14 days) time periods. During long (30-60 days) time periods, 
it seems as though this facilitory effect vanishes and there is no longer a difference 
between animals treated with DCS and those treated with vehicle. It is thus perceived 
that the lack of statistical power in this study, due to the small number of subjects, is 
possibly the largest contributor to the analyzed results found here. 
It is also arguable that the dosage used was insufficient to reveal group 
differences. Parnas, Weber, and Richardson (2005) were able to document the facilitory 
effect of DCS on conditioned fear extinction in rats using a dosage of only 15 mgkg. 
However, their design utilized multiple exposures to the drug. Weber et al. (2007) also 
used a dosage of 15 mgkg and were able to observe the supportive effects of DCS when 
"extinguishers" were distinguished from %on-extinguishers". If extinction memory 
processes can be facilitated using 15 mgkg then the current use of 30 mgkg is certainly 
substantiated. So conceivably, DCS may have a more narrow range of optimal dosages 
in terms of fear extinction. Flood, Morley, and Lanthom (1992) established that in the 
range of dosages from 2.5 to 50 mgkg, 10-39 mgkg seemed to produce the greatest 
amount of memory retention aid during a T-maze foot shock avoidance task. Despite the 
fact that their study employed subcutaneous injections, it did not differ greatly in terms of 
experimental goals. In essence, 30 mgkg administered intraperitoneally should promote 
extinction learning and foster a reduction in freezing behavior. 
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There is no known study that employed the same methods that are currently used. 
The idea of extinguishing animals to a criterion level spawned from the findings of 
Weber et al. (2007) who distinguished differences in DCS responsiveness when animals 
were identified as "extinguishers" and "non-extinguishers". The present aim was not to 
validate this claim specifically but to study the extended effects of DCS on fear 
extinction. Thus, all animals were given the opportunity to become "extinguishers" and 
none were identified as "non-extinguishers". In other words, although some animals did 
not reach a criterion freezing reduction in a short amount of time, these animals remained 
in the data analysis rather than being classified as "non-extinguishers". Presently, most 
animals reached a 50% reduction in their freezing levels by the 2nd or 3d extinction 
session. Nevertheless, those that did not reach similar levels until the 41h or 51h extinction 
session were all analyzed as equals. These seemingly small inter-animal differences may 
have actually played a larger role in the absence of an effect of DCS. Future 
investigations should examine the role DCS plays at low, moderate, and high amounts of 
extinction training as well as its role in fast, moderate, and slow extinguishers. 
Another methodological shortcoming may be that the 24 hour, 7 day, and 30 day 
delay groups were not run concurrently although all the animals began the initial 
handling phase at the same age. Because of this discrepancy, the 7 day rats were run at 
an age approximately 1-2 months older than those of the 24 hour group. The 30 day 
delay group rats, partially because of their long time delay periods, were also 1-2 months 
older than those of the 7 day delay group and 3-4 months older than those of the 24 hour 
delay group. The individual rat data results seem to be according to an age-dependent 
curve. That is, no animal in the 24 hour delay group took more than 4 extinction session 
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to reach the criterion level, and only 1 animal needed the 41h session. In the 7 day delay 
group, 1 animal took 4 extinction sessions, and 1 animal took 5 sessions. Finally, in the 
30 day delay group, when the animals were substantially older, 3 animals took 4 
extinction sessions to reach criterion and 2 needed the 5th session. Thus it seems as 
though older rats may become "non-extinguishers" or at least much slower extinguishers 
and in-turn may appear to be less responsive to DCS manipulation compared to much 
younger rats who were also given a much shorter time delay with which to recall 
extinction learning. In the present case, it is unknown whether such differences are due 
to memory impairments related with aging such that older rats may be unable to recall 
extinction learning after long delays or if the results stem from the greater amounts of 
time needed to learn the initial extinction training. Because these issue were not related 
to the current aims, further discussion is beyond the scope of this paper. What is known 
is that the co-variance of age and time delay group has created a possible problem in the 
data analysis and may have contributed to the results. 
General Discussion 
Although both experiments failed to validate previous research findings, there is 
useful information to take from them. For one, the effects of DCS may be small and not 
generalizable to all types of fear or anxiety related disorders, and more importantly, DCS 
may only be highly efficacious in a small population of experimental animals while many 
remain non-responsive. Such factors that could divide these groups are age, learning 
speed, and cognitive and memory load. 
Based on the current findings, it appears as though animal models of PTSD that 
employ DCS and fear extinction are of limited value. The premise, the idea that PTSD 
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may have its underpinnings based on a primitive learned fear response, is certainly valid. 
However, there are likely more complex neural deficits that largely contribute to the 
overall presentation of the disorder. An advantage humans with psychological disorders 
have is the ability of conscious re-evaluation of psychotic symptoms which has shown to 
be effective in reducing psychotic symptomatology (Rauch et al., 2006). As of yet, it is 
not known whether cognizant reappraisal of aversive stimuli relies on the same 
neurocircuitry as does behavioral therapies involved in extinction training (Rauch et al., 
2006). It has been said that emotional regulation activates the lateral prefrontal region 
whereas, as mentioned before, extinction training engages vmPFC (Rauch et al., 2006; 
Ochsner et al., 2002). And conversely, some studies have found similar activations for 
both of these processes (Rauch et al., 2006). Therefore, cognitive strategies may in fact 
appoint the same means of fear extinction (Rauch et al., 2006). Undoubtedly, if a 
correlation between these two processes is established, it will aid and guide the future of 
clinical treatment of PTSD. Conversely, since it assumed that experimental animals 
cannot engage evaluative cognition, if the capacity to do so is of considerable 
importance, then animal models of PTSD would be rather trivial. 
What can be drawn from this investigation is that DCS is only effective in certain 
neural states. Such beneficial effects may also be constrained by the idea that DCS can, 
under the right circumstances, act similar to an NMDA antagonist (Lanthorn, 1993). If 
the NMDA complex is stimulated at an inappropriate time, it can block subsequent LTP. 
In essence, this allows NMDA and endogenous NMDA agonists to perform like 
antagonists. This also means that DCS can take on properties of an NMDA antagonist 
(Lanthom, 1993). 
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Lanthom (1993) states that DCS may only have learning and memory enhancing 
effects when glycine levels are low and that at high levels of glycine, DCS has only the 
efficacy of itself alone which is minimal since DCS is only a partial agonist of the glycine 
site. As mentioned earlier, if glycine is already inundating binding sites on the NMDA 
receptor complex, the additional DCS may actually be detrimental, in effect, to learning, 
even presumably, fear extinction learning. These ideas may partially explain the results 
seen in experiment 1 where DCS may have stimulated the NMDA complex prematurely, 
causing a subsequent blockage in LTP during initial extinction training. 
Concluding Remarks 
Despite the fact that Experiment 2 was unable to uncover any significant effects 
of DCS on extinction, it did reveal that the counter-intuitive findings of Experiment 1 can 
be eliminated by extinguishing animals to criterion. Therefore, the overall conclusions 
extracted from this study at least partially confirm the findings of Lanthom (1993) as well 
as Weber, Hart, and Richardson (2007) by demonstrating the behavioral efficacy of DCS 
over extended periods of time. 
Many animal models of PTSD have chosen to focus on specific brain regions to 
explore the behavioral value of DCS treatment (Silvestri, Kyek, & Leblanc, 2007). In 
truth, there are several brain locales and risk factors that may play roles of varying 
importance in PTSD and other anxiety related disorders. For example, parental PTSD, 
prenatal environments with a mother with PTSD (Yehuda et al., 1998), genetic 
background (Wakizono et al., 2007; Stein et al., 2002), and smaller hippocampal volumes 
(Gilbertson et al., 2002) all appear to be worthy of note. Animal models have recognized 
increased amygdala responses as well as hypofrontality, especially in the medial 
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prefrontal region, as important regions for understanding PTSD (Davis & Whalen, 2001; 
Davis et al., 2005; Fendt & Fanselow, 1999). Therefore, while future investigations 
should continue to explore NMDA agonism's contribution to extinction learning both on 
a focal and distributed level, perhaps DCS, only a partial agonist for the NMDA system is 
not the most effective way to build a beneficial animal mogl  for human disorder. 
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